As of now, the lack of such studies represents a limitation of our work; nevertheless, our observations provide a clear foundation for the above-mentioned future studies to gain a deeper mechanistic understanding of how L. reuteri-mediated delivery of IL-22 ameliorates fatty liver disease. This evidence concerns the gene IL22 and fatty liver disease.